Cargando…
Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
The risk of cancer increases after transplantation. However, the consensus on immunosuppression (IS) adjustment after diagnosis of malignancy is lacking. Our study aims to assess the impact of IS adjustment on mortality of post-kidney transplant patients and allograft outcomes. We retrospectively re...
Autores principales: | Yang, Danwen, Thamcharoen, Natanong, Cardarelli, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947374/ https://www.ncbi.nlm.nih.gov/pubmed/31835895 http://dx.doi.org/10.3390/jcm8122189 |
Ejemplares similares
-
Unusual Presentation of Hemophagocytic Lymphohistiocytosis in a Kidney Transplant Patient
por: Yang, Danwen, et al.
Publicado: (2019) -
Papillary Renal Cell Carcinoma Presented With Supraclavicular Lymph Node Metastasis Without Renal Primary Lesion
por: Thamcharoen, Natanong, et al.
Publicado: (2013) -
Periprocedural Nebivolol for the Prevention of Contrast-Induced Acute Kidney Injury: A Systematic Review and Meta-analysis
por: Thamcharoen, Natanong, et al.
Publicado: (2015) -
188 COVID-19 and Kidney Transplant Recipients: Immunosuppression Management and Outcomes
Publicado: (2021) -
Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)